Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Gotch

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Immunogenetics|February 28, 2002
A CD45 polymorphism associated with abnormal splicing is absent in African populationsElma Z Tchilian, Ritu Dawes, Patricia A Ramaley, et al.
Journal of Translational Medicine|April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.
Plos One|April 16, 2015
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trialPatricia J Munseri, Arne Kroidl, Charlotta Nilsson, et al.
Science (New York, N.Y.)|January 10, 2009
Unsung hero Robert C. GalloGiovanni Abbadessa, Roberto Accolla, Fernando Aiuti, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Immunogenetics|February 28, 2002
A CD45 polymorphism associated with abnormal splicing is absent in African populationsElma Z Tchilian, Ritu Dawes, Patricia A Ramaley, et al.
Journal of Translational Medicine|April 14, 2011
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010Sarah Brinckmann, Kelly da Costa, Marit J van Gils, et al.
Plos One|April 16, 2015
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trialPatricia J Munseri, Arne Kroidl, Charlotta Nilsson, et al.
Science (New York, N.Y.)|January 10, 2009
Unsung hero Robert C. GalloGiovanni Abbadessa, Roberto Accolla, Fernando Aiuti, et al.
Pageof 8